Story 01 Funding

In one of the largest health AI funding rounds of the year, Qualified Health closed a $125 million Series B this week led by New Enterprise Associates, with participation from Anthropic, Menlo Ventures, and Transformation Capital. The raise signals growing investor conviction that the real value in clinical AI lies not in individual point solutions, but in the infrastructure layer that lets health systems deploy, govern, and scale them responsibly.

$125M

Qualified Health's Series B close — one of the year's largest health AI rounds — to scale generative AI deployment infrastructure across major hospital networks and the University of Texas System.

The Qualified Health platform gives health organizations the scaffolding to run generative AI at enterprise scale: governance frameworks, post-deployment monitoring, role-based access controls, a risk alert system, and a healthcare-specific AI agent builder for automating administrative workflows. The company had already announced partnerships with the University of Texas System and Jefferson Health before closing this round. CEO Justin Norden put it plainly: the goal is proving that AI can deliver "better patient outcomes, stronger financial sustainability, and meaningful relief for the clinicians who carry this system on their backs."

Story 02 Policy & Regulation

While federal AI healthcare regulation has remained largely stalled, state legislatures are filling the vacuum — and this week's activity shows how quickly the policy landscape is shifting at the local level.

In Georgia, SB 444 — a bill prohibiting health insurance coverage decisions from being based solely on AI systems — has passed both chambers and is now on the governor's desk. Alabama's SB 63 carries nearly identical intent, moving through committee to regulate AI in healthcare plan coverage determinations. And in Tennessee, Governor Bill Lee this week signed into law a ban on AI therapy bots, making Tennessee one of the first states to restrict AI in mental health service delivery by statute.

3+

States have moved major AI-in-healthcare bills to passage or signature in the past two weeks alone — Georgia, Alabama, and Tennessee among the most active, with Utah having passed nine AI-related bills in its most recent session.

The pattern is consistent: lawmakers want AI in the room but not in the chair. Decisions that affect patient access to care — whether an insurer approves a procedure, whether a patient in crisis gets a human or a bot — are being carved out as spaces where AI may assist but not decide alone. For health systems and insurers, the compliance implications are immediate and will require careful review of any automated denial or triage workflows currently in production.

Story 03 Clinical AI

Announced April 2, a new partnership between WELL Health Technologies and AliveCor offers a concrete example of the physician-AI collaboration model that healthcare leaders increasingly argue is the right template for clinical deployment. The two companies are integrating WELL's network of Canadian-registered cardiologists directly into AliveCor's AI-powered Kardia ECG platform, so that every AI-generated cardiac reading is reviewed and validated by a specialist physician before it reaches the patient.

24h

Cardiologist-reviewed ECG results are returned to patients in under 24 hours through the Kardia platform — reducing waits that would otherwise require in-person specialist visits, sometimes weeks away.

The model addresses one of the central anxieties around clinical AI: who is accountable when a reading is wrong? By building human expert review into the product architecture rather than treating it as an optional add-on, the partnership sidesteps the liability ambiguity that has slowed autonomous AI adoption in cardiology. Future phases may deploy AliveCor's Kardia 12L — a pocket-sized 12-lead ECG device — directly inside WELL's clinic network of more than 250 locations, extending point-of-care cardiac diagnostics to patients who currently lack routine access to specialist care.

Sources

APRIL 4, 2026